374 related articles for article (PubMed ID: 14983974)
1. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.
Crowell MD; Shetzline MA; Moses PL; Mawe GM; Talley NJ
Curr Opin Investig Drugs; 2004 Jan; 5(1):55-60. PubMed ID: 14983974
[TBL] [Abstract][Full Text] [Related]
2. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
Moskwa A; Boznańska P
Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.
Spiller R
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():25-31. PubMed ID: 17620085
[TBL] [Abstract][Full Text] [Related]
4. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
Gershon MD
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and its role in colonic function and in gastrointestinal disorders.
Costedio MM; Hyman N; Mawe GM
Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
[TBL] [Abstract][Full Text] [Related]
6. The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
Gershon MD; Tack J
Gastroenterology; 2007 Jan; 132(1):397-414. PubMed ID: 17241888
[TBL] [Abstract][Full Text] [Related]
7. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
[TBL] [Abstract][Full Text] [Related]
8. 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions.
Grundy D
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():63-7. PubMed ID: 18924445
[TBL] [Abstract][Full Text] [Related]
9. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
[TBL] [Abstract][Full Text] [Related]
10. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
Tonini M; Pace F
Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
[TBL] [Abstract][Full Text] [Related]
11. Role of serotonin in the pathophysiology of the irritable bowel syndrome.
Crowell MD
Br J Pharmacol; 2004 Apr; 141(8):1285-93. PubMed ID: 15100164
[TBL] [Abstract][Full Text] [Related]
12. Role of serotonin in gastrointestinal physiology and pathology.
Cirillo C; Vanden Berghe P; Tack J
Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
[TBL] [Abstract][Full Text] [Related]
13. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
[TBL] [Abstract][Full Text] [Related]
14. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
Zou BC; Dong L; Wang Y; Wang SH; Cao MB
Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
[TBL] [Abstract][Full Text] [Related]
15. Serotonin and GI clinical disorders.
Spiller R
Neuropharmacology; 2008 Nov; 55(6):1072-80. PubMed ID: 18687345
[TBL] [Abstract][Full Text] [Related]
16. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
Coates MD; Mahoney CR; Linden DR; Sampson JE; Chen J; Blaszyk H; Crowell MD; Sharkey KA; Gershon MD; Mawe GM; Moses PL
Gastroenterology; 2004 Jun; 126(7):1657-64. PubMed ID: 15188158
[TBL] [Abstract][Full Text] [Related]
17. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
[TBL] [Abstract][Full Text] [Related]
18. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
Manabe N; Wong BS; Camilleri M
Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
[TBL] [Abstract][Full Text] [Related]
19. [Intestinal motility disorders and visceral hypersensitivity in irritable bowel syndrome].
Ropert A; Bouguen G
Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S35-9. PubMed ID: 19303537
[TBL] [Abstract][Full Text] [Related]
20. Importance of 5-hydroxytryptamine receptors on intestinal afferents in the regulation of visceral sensitivity.
Greenwood-van Meerveld B
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():13-8. PubMed ID: 17620083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
